The 11 August 2008 edition of Forbes, on page 58, has a knee-slapping article on mediocre though profitable generic drug maker Teva Pharmaceutical. For years Teva has made lots of money copying other companies' drugs, is now buying up patent-protected drug lines that it can sell, only to find out that other generic companies are copying Teva's patent-protected drugs. What goes around, comes around.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment